Pembrolizumab plus axitinib: a new treatment option for patients with metastatic renal cell carcinoma

被引：9
|
作者：
Mollica, Veronica [1 ]
Di Nunno, Vincenzo [1 ]
Massari, Francesco [1 ]
机构：
[1] St Orsola Marcello Malpighi Hosp, Div Oncol, Via Albertoni 15, I-40138 Bologna, Italy
来源：
CHINESE CLINICAL ONCOLOGY | 2019年 / 8卷
关键词：
D O I：
10.21037/cco.2019.04.05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Pembrolizumab plus axitinib for the treatment of advanced renal cell carcinoma
    Spisarova, Martina
    Melichar, Bohuslav
    Vitaskova, Denisa
    Studentova, Hana
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (07) : 693 - 703
  • [2] Hypopituitarism induced by pembrolizumab plus axitinib in the treatment of metastatic renal cell carcinoma: A case report
    Hanawa, Kazushi
    Sawada, Norifumi
    Aikawa, Junki
    Otake, Yuko
    Kasai, Yoshifumi
    Mochizuki, Keito
    Shimura, Hiroshi
    Mochizuki, Takanori
    Kira, Satoru
    Mitsui, Takahiko
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [3] Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma
    Shimizu, Kazuki
    Tamada, Satoshi
    Matsuoka, Yudai
    Go, Ishun
    Okumura, Satoshi
    Ogawa, Masao
    Ohmachi, Tetsuji
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2022, 11 (03) : 205 - 209
  • [4] Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma
    Kazuki Shimizu
    Satoshi Tamada
    Yudai Matsuoka
    Ishun Go
    Satoshi Okumura
    Masao Ogawa
    Tetsuji Ohmachi
    International Cancer Conference Journal, 2022, 11 : 205 - 209
  • [5] Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib
    Airo, Giulia
    Maffezzoli, Michele
    Lazzarin, Alessandro
    Bianconcini, Michele
    Greco, Alessandro
    Buti, Sebastiano
    Leonetti, Alessandro
    IMMUNOTHERAPY, 2022, 14 (16) : 1297 - 1305
  • [6] Pembrolizumab Plus Axitinib Improves Survival in Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (06) : 336 - 337
  • [7] Real-world treatment modification of first-line axitinib plus pembrolizumab in patients with metastatic renal cell carcinoma (mRCC)
    Zakharia, Y.
    Thomaidou, D.
    Li, B.
    Siu, G.
    Levin, R.
    Vlahiotis, A.
    Zanotti, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1424
  • [8] Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma
    Spisarova, Martina
    Melichar, Bohuslav
    Vitaskova, Denisa
    Studentova, Hana
    FUTURE ONCOLOGY, 2021, 17 (03) : 241 - 254
  • [9] Axitinib for the treatment of metastatic renal cell carcinoma
    Parekh, Hiral
    Griswold, Julianne
    Rini, Brian
    FUTURE ONCOLOGY, 2016, 12 (03) : 303 - 311
  • [10] Axitinib in the treatment of metastatic renal cell carcinoma
    Ho, Thai H.
    Jonasch, Eric
    FUTURE ONCOLOGY, 2011, 7 (11) : 1247 - 1253
12345